Cargando…

Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics

Age represents an exclusion criterion in randomized clinical trials designed to test the efficacy and safety of inhaled drugs in asthma. As a consequence, data on efficacy and safety of inhaled corticosteroid (ICS) and long-acting β2 agonist (LABA) combinations in elderly asthmatics are scanty. Olde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benfante, Alida, Basile, Marco, Battaglia, Salvatore, Spatafora, Mario, Scichilone, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072519/ https://www.ncbi.nlm.nih.gov/pubmed/27789954 http://dx.doi.org/10.2147/TCRM.S103709

Ejemplares similares

Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations
por: Scichilone, Nicola, et al.
Publicado: (2013)

Asthma in the elderly: a different disease?
por: Battaglia, Salvatore, et al.
Publicado: (2016)

Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients
por: Scichilone, Nicola, et al.
Publicado: (2013)

Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics
por: Scichilone, N., et al.
Publicado: (2016)

Dynamic hyperinflation during the 6-min walk test in severely asthmatic subjects
por: Benfante, Alida, et al.
Publicado: (2018)

How Effective and Safe Is Bronchial Thermoplasty in “Real Life” Asthmatics Compared to Those Enrolled in Randomized Clinical Trials?
por: Arrigo, Rita, et al.
Publicado: (2016)

ICS/LABA Combined With Subcutaneous Immunotherapy Modulates the Th17/Treg Imbalance in Asthmatic Children
por: Dai, Huan, et al.
Publicado: (2022)

Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics
por: Principe, Stefania, et al.
Publicado: (2019)

Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma
por: Caswell-Smith, Rachel, et al.
Publicado: (2017)

EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
por: Buhl, Roland, et al.
Publicado: (2023)

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
por: Hizawa, Nobuyuki
Publicado: (2015)

Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler
por: Price, David B., et al.
Publicado: (2016)

Echocardiographic Evaluation of the Cardiac Chambers in Asthmatic Patients: The BADA (Blood Pressure Levels, Clinical Features and Markers of Subclinical Cardiovascular Damage of Asthma Patients) Study-ECO
por: Di Raimondo, Domenico, et al.
Publicado: (2022)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
por: Singh, Dave, et al.
Publicado: (2019)

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
por: Rodrigo, Gustavo J, et al.
Publicado: (2017)

The geriatric asthma: pitfalls and challenges
por: Benfante, Alida, et al.
Publicado: (2016)

The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1
por: Janeva, Elena Jovanovska, et al.
Publicado: (2015)

Preoperative Diagnosis of Abdominal Extra-Adrenal Paragangliomas with Fine-Needle Biopsy
por: Nikas, Ilias P., et al.
Publicado: (2022)

Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
por: Oh, Yeon-Mok
Publicado: (2017)

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
por: Vanfleteren, Lowie, et al.
Publicado: (2018)

Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
por: Vanfleteren, Lowie E.G.W., et al.
Publicado: (2019)

CT-guided fine needle aspiration cytology diagnosis of extra-adrenal pheochromocytoma
por: Rangaswamy, M, et al.
Publicado: (2010)

LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
por: Rogliani, Paola, et al.
Publicado: (2018)

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
por: Aziz, Mohamed Ismail Abdul, et al.
Publicado: (2018)

Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids
por: Sonnappa, Samatha, et al.
Publicado: (2017)

Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Applicability of the MASK-Air(®) App to Severe Asthma Treated with Biologic Molecules: A Pilot Study
por: Benfante, Alida, et al.
Publicado: (2022)

Response to “CT-guided fine needle aspiration cytology diagnosis of extra-adrenal pheochromocytoma”
por: Bhargav, PRK
Publicado: (2012)

Beclomethasone/Formoterol in Extra-Fine Formulation Improves Small Airway Dysfunction in COPD Patients
por: Pisi, Roberta, et al.
Publicado: (2021)

Inferring visual space from ultra-fine extra-retinal knowledge of gaze position
por: Zhao, Zhetuo, et al.
Publicado: (2023)

Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS
por: Van Eickles, Daniela, et al.
Publicado: (2015)

Predictors of ICS/LABA prescribing in COPD patients: a study from general practice
por: Drivenes, Elin, et al.
Publicado: (2014)

ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts
por: Dhar, Raja, et al.
Publicado: (2022)

Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group
por: Stanford, Richard H., et al.
Publicado: (2015)

Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations [Corrigendum]
Publicado: (2013)

Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations [Corrigendum]
Publicado: (2013)

Prevalence of Arterial Hypertension and Characteristics of Nocturnal Blood Pressure Profile of Asthma Patients According to Therapy and Severity of the Disease: The BADA Study
por: Di Raimondo, Domenico, et al.
Publicado: (2020)

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials
por: Sethi, Sanjay, et al.
Publicado: (2020)

Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMA
por: Vos, Wim, et al.
Publicado: (2016)

Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
por: Tariq, Syed Mohammad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0at5a10rm9laojd4b5q7teihqv